A plant long brewed for its stimulating and sedating effects in Southeast Asia has found its way into American gas stations and online carts as an easy energy aid, and into the lives of families who never imagined a leaf could take a son away. Now the nation is caught between a federal government that first moved to restrict its concentrated derivative, 7-OH, and then reversed course, and a growing body of evidence that the risks are real, the deaths are mounting, and the money behind the product's legality is substantial. What remains unsettled is whether the pull of commerce and lobbying wil
Parents Whose Sons Died After Kratom Use Warn of the Substance's Deadly Risks
She tells them about her son.
Why does this story land so hard? Kratom sounds almost ordinary.
That's the point. These young men thought it was like coffee, or safer than Red Bull. It's sold at gas stations, so it looked harmless.
What do the numbers say?
The CDC found kratom in more than 5,000 overdose deaths from 2020 to 2024. A toxicologist says deaths linked to it are up about tenfold since 2014.
Careful, though. Detected in a death isn't the same as caused it. Two of the four sons had mitragynine alone listed as the cause. The other two also had medications involved.
And the tenfold figure?
That's one toxicologist's estimate, based on his lab's casework. It's informed, but it isn't a national count.
What about the policy reversal?
In July the government said it would restrict 7-OH and three related substances. Last month HHS recommended allowing 20 times more 7-OH in products.
And the lobbying money is documented in filings. But whether it influenced that decision is not established. HHS says it didn't, and the reporting doesn't show a direct link.
Kolodny compares it to Purdue.
That's his comparison, an expert's opinion. The industry's counterpoint is that natural kratom differs from chemically manipulated products, and we don't have data here splitting deaths between the two.
What remains is a mother in convenience stores, telling clerks about her son.
The Pulse
- Families who lost young sons to kratom are speaking publicly, describing deaths that came without warning during ordinary moments like a card game.
- The federal government announced restrictions on 7-OH in July, then reversed course last month, raising allowable levels twenty-fold and stunning former officials.
- The CDC has linked kratom to more than 5,000 overdose deaths from 2020 to 2024, while the product sits on shelves in tens of thousands of stores.
- Public filings show millions flowing from the American Kratom Association toward lobbying the FDA, HHS, the White House and Congress, drawing comparisons to Purdue Pharma's OxyContin campaign.
- HHS denies outside pressure shaped its decision, and the question now is whether the loosened 7-OH stance survives and whether lobbying draws closer scrutiny.
A plant long brewed for its stimulating and sedating effects in Southeast Asia has found its way into American gas stations and online carts as an easy energy aid, and into the lives of families who never imagined a leaf could take a son away. Now the nation is caught between a federal government that first moved to restrict its concentrated derivative, 7-OH, and then reversed course, and a growing body of evidence that the risks are real, the deaths are mounting, and the money behind the product's legality is substantial. What remains unsettled is whether the pull of commerce and lobbying will outweigh the grief of the people left behind.
Susan Eppard's son Matthew collapsed while playing cards with friends. Those trying to revive him worked on him for a long time, and when Eppard arrived she was kept outside at first. She sat on the ground screaming for God to keep her child here. When they finally let her in, she knelt and kissed his forehead and found him cold and gray. Matthew had been taking kratom, which he described to her as being like coffee, because he had read the plant belonged to the coffee family. His death was attributed solely to mitragynine, kratom's main opioid compound.
Kratom grows in Southeast Asia, where people have chewed its leaves or brewed them into a stimulating tea for generations. In the United States it has become a billion-dollar business, sold online and in tens of thousands of stores, including gas stations, and legal in most states. The industry presents it as a mild stimulant and a possible aid for opioid recovery, an image the American Kratom Association has helped build.
Four families told 60 Minutes their sons, now dead, started using it for energy or to ease away from alcohol. One friend had told a young man kratom was safer than Red Bull. Health experts warn the risk is real. The CDC has detected kratom in more than 5,000 overdose deaths from 2020 to 2024, and a toxicologist who has analyzed thousands of such deaths says kratom-linked fatalities have risen roughly tenfold since 2014. The FDA advises consumers not to use it.
Federal policy has swung back and forth. In July the government moved to restrict 7-OH, a concentrated synthetic derivative. Last month HHS reversed course and proposed raising allowable levels twenty-fold, a decision that stunned former officials. Public filings show a steady stream of money, much of it from the Kratom Association, aimed at lobbying federal agencies and Congress. HHS says neither contributions nor outside pressure shaped its choice. Eppard, meanwhile, visits convenience stores and asks clerks whether they know what they are selling. Often they do not, so she tells them about her son. "We all just miss him terrible," she said.
Susan Eppard's son Matthew collapsed without warning while playing cards with friends. Those around him tried to revive him for a long time. When Eppard arrived, she was not allowed inside at first, so she sat on the ground outside, screaming for God to keep her child here. Eventually they let her in. She knelt and kissed his forehead, and found him cold and gray.
Matthew had been taking kratom. He had told his mother it was like coffee, because he had read that the plant belongs to the coffee family. His death was attributed solely to mitragynine, the main opioid compound in kratom.
Kratom comes from a tree native to Southeast Asia, where people have chewed the leaves or boiled them into a stimulating tea with opioid effects for generations. In the United States it has become a billion-dollar industry. Products are sold online and in tens of thousands of stores, including gas stations, and the substance can be as easy to buy as a bag of chips. It is legal in most states.
The industry presents kratom as a mild stimulant that can also help people recover from opioid addiction. The American Kratom Association, a consumer advocacy and lobbying group, has helped shape that image. It describes natural kratom as a safe food that many people use as an herbal supplement for health, wellbeing or an energy boost.
Four families told 60 Minutes that their sons, all now dead, began using it for reasons like these. Wendy Chamberlain said her son Joe wanted energy, and a friend told him kratom was safer than Red Bull. Patti Wheeler said her son Wyatt thought it was helping him ease away from alcohol. Joe's death, like Matthew's, was attributed solely to mitragynine. For Wyatt Wheeler and for Daniel Bregger, the fourth young man, the causes of death listed mitragynine along with prescription or over-the-counter medications.
Health experts say the risk is real. Dr. Andrew Kolodny, medical director of the Opioid Policy Research Collaborative at Brandeis University, says kratom's effects closely resemble those of oxycodone, heroin and even fentanyl. The Centers for Disease Control and Prevention has detected kratom in more than 5,000 overdose deaths from 2020 to 2024. Justin Brower, a toxicologist at NMS Labs, a forensic testing facility 40 minutes outside Philadelphia, says he has analyzed thousands of deaths involving kratom. He says dozens and dozens were attributed to kratom alone, with no other drugs, and that kratom-linked fatalities have risen roughly tenfold since 2014. The Food and Drug Administration warns consumers not to use it, citing liver toxicity, seizures and substance use disorder.
Federal policy has moved in both directions. In July, with concern growing over kratom-derived products, including the concentrated synthetic substance 7-OH, the government announced it would restrict 7-OH and three related substances. Last month the Department of Health and Human Services changed course. Among its new recommendations was raising the amount of 7-OH allowed in products by 20-fold. Former FDA Commissioner Dr. Marty Makary and former senior HHS advisor Calley Means were among the officials stunned by the decision.
60 Minutes found public filings from the past decade showing a steady flow of money, much of it from the American Kratom Association, earmarked for lobbying the FDA, HHS, the White House and Congress. Millions of dollars have gone toward keeping kratom legal, and more has come as political contributions and investments. Kolodny compared the effort to Purdue Pharma's campaign for OxyContin, saying some of the scientists Purdue hired to head off regulators now work for the Kratom Association, downplaying risks and exaggerating the number of people who benefit.
HHS declined an interview but said in a statement that neither political contributions nor outside pressure influenced its decision. The American Kratom Association stressed the difference between natural kratom and what it called dangerous chemically manipulated products.
Eppard says she cannot believe kratom is still sold in any form. She goes into convenience stores and asks employees whether they know what they are selling. Often they do not, so she tells them about her son. "We all just miss him terrible," she said. The question now is whether the loosened federal stance on 7-OH holds, and whether the lobbying behind it draws closer scrutiny.
Notable Quotes
Some of the same scientists Purdue Pharma hired are now working for the Kratom Association, downplaying the risks.— Dr. Andrew Kolodny, Brandeis University
Neither political contributions nor outside pressure influenced the decision.— HHS statement to 60 Minutes